As far as we know, this study is the first report describing the role of HSF1 in the clinical pathology and prognosis of pancreatic cancer and demonstrating that HSF1 functions by regulating the SMAC-mediated mitochondrial pathway to inhibit pancreatic cancer cell apoptosis. The gene discussed is DIABLO; the disease is pancreatic neoplasm.